BGLAP and chronic myelogenous leukemia, BCR-ABL1 positive: In the case of CML patients on Imatinib, the assessment of bone health, a combination of BMD and bone turnover marker assays such as CTX-1 and osteocalcin, can be used to help in determining bone-modeled changes earlier than BMD.